Registration closes tonight!

Local 196 is pleased to welcome

Ms. Violetta Ambrozuk, RN, and

Dr. Michael Smylie, MD

for our February 12, 2018 Education Dinner.

We are pleased to have a member from Local 196, Violetta, speak about her journey beating skin cancer along with her oncologist, Dr. Smylie.

Ms. Violetta Ambrozuk is a Registered Nurse and a member of Local 196. In 2009, she was diagnosed with melanoma while in her last year of nursing school. She has been very vocal in sharing her cancer story in hopes of educating others on the dangers of tanning bed use and sun safety. In addition she’s been actively involvement with multiple organizations whose main goal is promotion of sun safety education, and skin cancer awareness and prevention.

Dr. Michael Smylie is Medical Oncologist, Cross Cancer Institute in Edmonton, Alberta; holds an academic appointment as Professor, Department of Oncology, University of Alberta, Edmonton.  He is the past Site Leader for the Clinical Trials Committee, Cross Cancer Institute and past leader of the National Canada Institute of Cancer (NCIC) melanoma group.  Dr. Smylie has chaired several National Melanoma meetings and is the past chair of the Canadian Melanoma Conference.

Dr. Smylie graduated with an Honours B.SC. in Physical Sciences, then attended medical school at the University of Leicester, Leicester, United Kingdom. He was awarded a Distinction in Pathology and received the Carl Zeiss prize for best performance in Pathology.  He completed his residency in internal medicine at the University of Saskatchewan, and his medical oncology fellowship at the University of Ottawa, Ottawa, Ontario.

He is very active in designing and participating in clinical trials in malignant melanoma and holds an interest in lung cancer.  He is an active member of the Mary Johnston Melanoma Professorship in Edmonton, Alberta.  His major research interest is clinical research in targeted therapy and immunotherapy in melanoma.

He is currently a member of the small molecule immune checkpoint inhibitor program at the University of Alberta, and is doing collaborative research into novel predictors of response to immunotherapy.

Dr. Smylie sits on several different Advisory Boards focusing on melanoma, and has given several national and international talks on melanoma.

This event is open to members & duespayers of

Local 196 only.


To attend, please click the link on the right under Local 196 Events and register using your personal email.

Paper or E-Tickets required for entry.

Registration closes  February 7, 2018

If you have any issues with registration, please email the Local Education Committee at